{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:24:44Z","timestamp":1790267084260,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700904"],"award-info":[{"award-number":["2021YFC2700904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171395"],"award-info":[{"award-number":["82171395"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071412"],"award-info":[{"award-number":["82071412"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1136\/ard-2024-226057","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T13:20:21Z","timestamp":1725542421000},"page":"491-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5360-5660","authenticated-orcid":false,"given":"Guoyong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2024-226057_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1136\/ard-2024-226057_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"The Lancet"},{"key":"10.1136\/ard-2024-226057_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1136\/ard-2024-226057_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40478-014-0154-2","article-title":"Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy","volume":"2","author":"Aouizerate","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1136\/ard-2024-226057_bib5","first-page":"493","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurol (ECronicon)"},{"key":"10.1136\/ard-2024-226057_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1136\/ard-2024-226057_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1136\/ard-2024-226057_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-017-1383-0","article-title":"RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis","volume":"19","author":"Su\u00e1rez-Calvet","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2024-226057_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/nan.12498","article-title":"Expression of myxovirus\u2010resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis","volume":"45","author":"Soponkanaporn","year":"2019","journal-title":"Neuropathology Appl Neurobio"},{"key":"10.1136\/ard-2024-226057_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/path.4346","article-title":"Altered RIG-I\/DDX58-mediated innate immunity in dermatomyositis","volume":"233","author":"Su\u00e1rez-Calvet","year":"2014","journal-title":"J Pathol"},{"key":"10.1136\/ard-2024-226057_bib11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awy105","article-title":"JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis","volume":"141","author":"Ladislau","year":"2018","journal-title":"Brain (Bacau)"},{"key":"10.1136\/ard-2024-226057_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2016.08.004","article-title":"The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies","volume":"75","author":"Bhattarai","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1136\/ard-2024-226057_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coi.2020.10.013","article-title":"The innate immune system and cell death in autoinflammatory and autoimmune disease","volume":"67","author":"Place","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1136\/ard-2024-226057_bib14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1136\/ard-2024-226057_bib15","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways","volume":"19","author":"Wang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1136\/ard-2024-226057_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1136\/ard-2024-226057_bib17","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/keaa473","article-title":"PKM2-dependent glycolysis promotes skeletal muscle cell pyroptosis by activating the NLRP3 inflammasome in dermatomyositis\/polymyositis","volume":"60","author":"Liu","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"10.1136\/ard-2024-226057_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41467-021-27875-4","article-title":"Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies","volume":"13","author":"Kamiya","year":"2022","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2024-226057_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/art.42071","article-title":"Contribution of Necroptosis to Myofiber Death in Idiopathic Inflammatory Myopathies","volume":"74","author":"Peng","year":"2022","journal-title":"Arthritis & Rheumatology"},{"key":"10.1136\/ard-2024-226057_bib20","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226057_bib21","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.apsb.2022.12.009","article-title":"Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects","volume":"13","author":"Wei","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1136\/ard-2024-226057_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.21037\/atm-20-3719","article-title":"Environmental triggers of dermatomyositis: a narrative review","volume":"9","author":"Bax","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1136\/ard-2024-226057_bib23","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1093\/rheumatology\/kead117","article-title":"IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis","volume":"62","author":"Liu","year":"2023","journal-title":"Rheumatol Sunnyvale"},{"key":"10.1136\/ard-2024-226057_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2024-226057_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12955","article-title":"The role of interferons type I, II and III in myositis: a review","volume":"31","author":"Bolko","year":"2021","journal-title":"Brain Pathol"},{"key":"10.1136\/ard-2024-226057_bib26","first-page":"199","article-title":"Idiopathic inflammatory myopathies: one year in review 2022","volume":"41","author":"Dourado","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2024-226057_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002864","article-title":"Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider","volume":"9","author":"Rodr\u00edguez-Carrio","year":"2023","journal-title":"RMD Open"},{"key":"10.1136\/ard-2024-226057_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard-2024-226057_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fnmol.2018.00480","article-title":"PKR: a Kinase to Remember","volume":"11","author":"Gal-Ben-Ari","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1136\/ard-2024-226057_bib30","first-page":"e448","article-title":"Pathologic Features of Anti-Mi-2 Dermatomyositis","volume":"96","author":"Tanboon","year":"2021","journal-title":"Neurol (ECronicon)"},{"key":"10.1136\/ard-2024-226057_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/BOR.0000000000000816","article-title":"Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy","volume":"33","author":"Kim","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard-2024-226057_bib32","first-page":"e739","article-title":"Dermatomyositis: muscle Pathology According to Antibody Subtypes","volume":"98","author":"Tanboon","year":"2022","journal-title":"Neurol (ECronicon)"},{"key":"10.1136\/ard-2024-226057_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/nan.12519","article-title":"Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis","volume":"45","author":"Uruha","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1136\/ard-2024-226057_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1042580","article-title":"Comparison of cytokine\/chemokine profiles between dermatomyositis and anti-synthetase syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Neurol"},{"key":"10.1136\/ard-2024-226057_bib35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/BOR.0000000000000653","article-title":"Interferon-signature in idiopathic inflammatory myopathies","volume":"31","author":"Gallay","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard-2024-226057_bib36","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","article-title":"Where are we moving in the classification of idiopathic inflammatory myopathies?","volume":"33","author":"Tanboon","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1136\/ard-2024-226057_bib37","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.4049\/jimmunol.150.5.1715","article-title":"Control of IFN-inducible MxA gene expression in human cells","volume":"150","author":"Ronni","year":"1993","journal-title":"J Immunol"},{"key":"10.1136\/ard-2024-226057_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1136\/ard-2024-226057_bib39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ajpath.2013.06.003","article-title":"Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response","volume":"183","author":"Fr\u00e9ret","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1136\/ard-2024-226057_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12020-012-9751-7","article-title":"Atrogin-1, MuRF-1, and sarcopenia","volume":"43","author":"Gumucio","year":"2013","journal-title":"Endocrine"},{"key":"10.1136\/ard-2024-226057_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1136\/ard-2024-226057_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jir.2010.0076","article-title":"Human MxA Protein: an Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity","volume":"31","author":"Haller","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1136\/ard-2024-226057_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr Opin Virol"},{"key":"10.1136\/ard-2024-226057_bib44","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/MMBR.00027-06","article-title":"Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action","volume":"70","author":"Garc\u00eda","year":"2006","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1136\/ard-2024-226057_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11033-010-0087-1","article-title":"IL-29 and IFN-\u03b1 regulate the expression of MxA, 2\u2032,5\u2032-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells","volume":"38","author":"Chai","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1136\/ard-2024-226057_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656573","article-title":"L-Leucine Promotes STAT1 and ISGs Expression in TGEV-Infected IPEC-J2 Cells via mTOR Activation","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2024-226057_bib47","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa2117912","article-title":"Trial of Intravenous Immune Globulin in Dermatomyositis","volume":"387","author":"Aggarwal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2024-226057_bib48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2011.07.012","article-title":"Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function","volume":"35","author":"Gao","year":"2011","journal-title":"Immunity"},{"key":"10.1136\/ard-2024-226057_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.molcel.2021.11.019","article-title":"RNA circles with minimized immunogenicity as potent PKR inhibitors","volume":"82","author":"Liu","year":"2022","journal-title":"Mol Cell"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724005703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724005703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2024-226057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:33:32Z","timestamp":1762086812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724005703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0003496724005703"],"URL":"https:\/\/doi.org\/10.1136\/ard-2024-226057","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2024-226057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}